These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 15307119)

  • 1. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites.
    Welch L; Ringen K; Bingham E; Dement J; Takaro T; McGowan W; Chen A; Quinn P
    Am J Ind Med; 2004 Sep; 46(3):207-18. PubMed ID: 15307119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beryllium disease among construction trade workers at Department of Energy nuclear sites.
    Welch LS; Ringen K; Dement J; Bingham E; Quinn P; Shorter J; Fisher M
    Am J Ind Med; 2013 Oct; 56(10):1125-36. PubMed ID: 23794247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of hearing loss among older construction and trade workers at Department of Energy nuclear sites.
    Dement J; Ringen K; Welch L; Bingham E; Quinn P
    Am J Ind Med; 2005 Nov; 48(5):348-58. PubMed ID: 16254949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beryllium disease among construction trade workers at Department of Energy nuclear sites: A follow-up.
    Cloeren M; Dement J; Gaitens J; Hines S; Diaz L; Tembunde Y; Cranford K; Shorter J; Mosier T; Ringen K;
    Am J Ind Med; 2022 Sep; 65(9):708-720. PubMed ID: 35833586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality of older construction and craft workers employed at Department of Energy (DOE) nuclear sites.
    Dement JM; Ringen K; Welch LS; Bingham E; Quinn P
    Am J Ind Med; 2009 Sep; 52(9):671-82. PubMed ID: 19670258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of respiratory diseases among construction and trade workers at Department of Energy nuclear sites.
    Dement JM; Welch L; Bingham E; Cameron B; Rice C; Quinn P; Ringen K
    Am J Ind Med; 2003 Jun; 43(6):559-73. PubMed ID: 12768606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
    Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
    Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance.
    Stange AW; Furman FJ; Hilmas DE
    Am J Ind Med; 2004 Nov; 46(5):453-62. PubMed ID: 15490468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airways obstruction among older construction and trade workers at Department of Energy nuclear sites.
    Dement JM; Welch L; Ringen K; Bingham E; Quinn P
    Am J Ind Med; 2010 Mar; 53(3):224-40. PubMed ID: 20025074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.
    Schuler CR; Virji MA; Deubner DC; Stanton ML; Stefaniak AB; Day GA; Park JY; Kent MS; Sparks R; Kreiss K
    Scand J Work Environ Health; 2012 May; 38(3):270-81. PubMed ID: 21877099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive diagnosis of chronic beryllium disease in workers exposed to hazardous dust in Israel.
    Fireman E; Mazor O; Kramer M; Priel I; Lerman Y
    Occup Environ Med; 2010 Sep; 67(9):631-5. PubMed ID: 19955573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of a program to prevent beryllium disease.
    Thomas CA; Deubner DC; Stanton ML; Kreiss K; Schuler CR
    Am J Ind Med; 2013 Jul; 56(7):733-41. PubMed ID: 23450749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic beryllium disease prevention program. Office of Environment, Safety and Health, Department of Energy. Final rule.
    Fed Regist; 1999 Dec; 64(235):68854-914. PubMed ID: 11010683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing BeLPT criteria for beryllium sensitization.
    Middleton DC; Fink J; Kowalski PJ; Lewin MD; Sinks T
    Am J Ind Med; 2008 Mar; 51(3):166-72. PubMed ID: 18181198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.
    Kreiss K; Wasserman S; Mroz MM; Newman LS
    J Occup Med; 1993 Mar; 35(3):267-74. PubMed ID: 8455096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of beryllium sensitization in a low-exposed former nuclear weapons cohort from the Cold War era.
    Mikulski MA; Leonard SA; Sanderson WT; Hartley PG; Sprince NL; Fuortes LJ
    Am J Ind Med; 2011 Mar; 54(3):194-204. PubMed ID: 21298695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.
    Kent MS; Robins TG; Madl AK
    Appl Occup Environ Hyg; 2001 May; 16(5):539-58. PubMed ID: 11370934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a medical examination program for former workers at a Department of Energy national laboratory.
    Breysse PN; Weaver V; Cadorette M; Wiggs L; Curbow B; Stefaniak A; Melius J; Newman L; Smith H; Schwartz B
    Am J Ind Med; 2002 Nov; 42(5):443-54. PubMed ID: 12382258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beryllium hypersensitivity and chronic beryllium lung disease.
    Santo Tomas LH
    Curr Opin Pulm Med; 2009 Mar; 15(2):165-9. PubMed ID: 19532033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed.
    Henneberger PK; Goe SK; Miller WE; Doney B; Groce DW
    J Occup Environ Hyg; 2004 Oct; 1(10):648-59. PubMed ID: 15631056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.